Package 50090-7110-0

{"route": ["ORAL"], "spl_id": "4ecbc3fb-72e9-430a-9903-1da1e65ed1c7", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["8ae81b03-b447-4a3f-8ed9-ebf75ee52b49"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7110-0)", "package_ndc": "50090-7110-0", "marketing_start_date": "20240311"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7110-1)", "package_ndc": "50090-7110-1", "marketing_start_date": "20240311"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-7110-2)", "package_ndc": "50090-7110-2", "marketing_start_date": "20240311"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "50090-7110_4ecbc3fb-72e9-430a-9903-1da1e65ed1c7", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50090-7110", "generic_name": "bupropion hydrochloride", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210081", "marketing_category": "ANDA", "marketing_start_date": "20180830", "listing_expiration_date": "20261231"}